Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 mars 2001 05h00 HE | Source: CellaVision AB

CellaVision, Lund, Sweden has obtained FDA clearance to introduce its DiffMaster(TM) Octavia, an in-vitro diagnostic device, on the U.S. market.

DiffMaster Octavia is an automated cell-locating device for differential count of white blood cells and characterization of red morphology, today conducted through manual microscopy. It is based on a...
28 nov. 2000 06h00 HE | Source: CellaVision AB

CellaVision signs Letter of Intent with Sysmex

CellaVision AB (situated in Sweden) and Sysmex Europe GmbH (situated in Germany) have signed a Letter of Intent regarding distribution of CellaVision's products in selected countries, including...